A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus

Biomaterials

Volumn 35, Issue 13, 2014, Pages 4175-4184

  Varga, Norbert ^a   Sutkeviciute, Ieva ^b,c,d   Ribeiro Viana, Renato ^e   Berzi, Angela ^f   Ramdasi, Rasika ^g   Daghetti, Anna ^a   Vettoretti, Gerolamo ^a   Amara, Ali ^g   Clerici, Mario ^a,h   Rojo, Javier ^e   Fieschi, Franck ^b,c,d   Bernardi, Anna ^a,i  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIV GRENOBLE ALPES   (France)

^c CEA GRENOBLE   (France)

^d INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^e INSTITUTO DE INVESTIGACIONES QUÍMICAS   (Spain)

^f UNIVERSITY OF MILAN   (Italy)

^g SAINT LOUIS HOSPITAL   (France)

^h IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

ⁱ CNR   (Italy)

Author keywords

DC SIGN; Dengue; Glycodendrimers; Glycomimetics; HIV; Nanotechnology

Indexed keywords

BINDING SITES; CARBOHYDRATES; CELLS; CHEMICAL STABILITY; CYTOLOGY; LIGANDS; NANOTECHNOLOGY; PLASMONS; SURFACE PLASMON RESONANCE; VIRUSES;

ANTIGEN PRESENTING CELLS; ANTIVIRAL PROPERTIES; DC SIGNS; DENGUE; ENVELOPE GLYCOPROTEINS; GLYCODENDRIMERS; GLYCOMIMETICS; HIGH-AFFINITY INHIBITORS;

DISEASES;

ANTIVIRUS AGENT; CARBOHYDRATE; CD209 ANTIGEN; DENDRIMER; HEXA(2 PROPYNYLOXYMETHYL) BISPENTAERYTHRITOL; HEXAVALENT GLYCODENDRIMER; LIGAND; NONAVALENT GLYCODENDRIMER; TETRAVALENT GLYCODENDRIMER; TRIVALENT GLYCODENDRON; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; LECTIN;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CYCLOADDITION; CYTOTOXICITY; DENGUE; DENGUE VIRUS; DRUG SYNTHESIS; GEL PERMEATION CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IC 50; INFECTION PREVENTION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; RAJI CELL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SURFACE PLASMON RESONANCE; T LYMPHOCYTE; VIRUS ENTRY; CELL LINE; CHEMISTRY; DRUG EFFECTS; HUMAN; PATHOGENICITY;

DENGUE VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIVIRAL AGENTS; CELL ADHESION MOLECULES; CELL LINE; DENDRIMERS; DENGUE VIRUS; HIV-1; HUMANS; LECTINS, C-TYPE; RECEPTORS, CELL SURFACE; SURFACE PLASMON RESONANCE;

EID: 84896726186     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.01.014     Document Type: Article

References (40)

1. van Kooyk Y., Geijtenbeek T.B.H. DC-sign: escape mechanism for pathogens. Nat Rev Immunol 2003, 3:697-709.
2. Anderluh M., Jug G., Svajger U., Obermajer N. DC-SIGN antagonists, a potential new class of anti-infectives. Curr Med Chem 2012, 19:992-1007.
3. Date A.A., Destache C.J. Areview of nanotechnological approaches for the prophylaxis of HIV/AIDS. Biomaterials 2013, 34:6202-6228.
4. Borrok M.J., Kiessling L.L. Non-carbohydrate inhibitors of the lectin DC-SIGN. JAm Chem Soc 2007, 129:12780-12785.
5. Garber K.C.A., Wangkanont K., Carlson E.E., Kiessling L.L. Ageneral glycomimetic strategy yields non-carbohydrate inhibitors of DC-SIGN. Chem Commun 2010, 46:6747-6749.
6. Mangold S.L., Prost L.R., Kiessling L.L. Quinoxalinone inhibitors of the lectin DC-SIGN. Chem Sci 2012, 3.
7. Tran T.H., El Baz R., Cuconati A., Arthos J., Jain P., Khan Z.K. Anovel high-throughput screening assay to identify inhibitors of HIV-1 gp120 protein interaction with DC-SIGN. JAntivir Antiretrovir 2011, 3:49-54.
8. Lasala F., Arce E., Otero J.R., Rojo J., Delgado R. Mannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in trans. Antimicrob Agents Chemother 2003, 47:3970-3972.
9. Rojo J., Delgado R. Glycodendritic structures: promising new antiviral drugs. JAntimicrob Chemother 2004, 54:579-581.
10. Bernardi A., Cheshev P. Interfering with the sugar code: design and synthesis of oligosaccharide mimics. Chem. Eur. J. 2008, 14:7434-7441.
11. de Witte L., Nabatov A., Pion M., Fluitsma D., de Jong M.A., de Gruijl T., et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007, 13:367-371.
12. Sattin S., Daghetti A., Thepaut M., Berzi A., Sanchez-Navarro M., Tabarani G., et al. Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation. ACS Chem Biol 2010, 5:301-312.
13. Berzi A., Reina J.J., Ottria R., Sutkeviciute I., Antonazzo P., Sanchez-Navarro M., et al. Aglycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models. AIDS 2012, 26:127-137.
14. Thepaut M., Guzzi C., Sutkeviciute I., Sattin S., Ribeiro-Viana R., Varga N., et al. Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design. JAm Chem Soc 2013, 135:2518-2529.
15. Varga N., Sutkeviciute I., Guzzi C., McGeagh J., Petit-Haertlein I., Gugliotta S., et al. Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside. Chem. Eur. J. 2013, 19:4786-4797.
16. Cambi A., de Lange F., van Maarseveen N.M., Nijhuis M., Joosten B., van Dijk E.M., et al. Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells. JCell Biol 2004, 164:145-155.
17. de Bakker B.I., de Lange F., Cambi A., Korterik J.P., van Dijk E.M., van Hulst N.F., et al. Nanoscale organization of the pathogen receptor DC-SIGN mapped by single-molecule high-resolution fluorescence microscopy. Chemphyschem 2007, 8:1473-1480.
18. Luczkowiak J., Sattin S., Sutkeviciute I., Reina J.J., Sanchez-Navarro M., Thepaut M., et al. Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection. Bioconjug Chem 2011, 22:1354-1365.
19. Wang S.K., Liang P.H., Astronomo R.D., Hsu T.L., Hsieh S.L., Burton D.R., et al. Targeting the carbohydrates on HIV-1: interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN. Proc Natl Acad Sci USA 2008, 105:3690-3695.
20. Becer C.R., Gibson M.I., Geng J., Ilyas R., Wallis R., Mitchell D.A., et al. High-affinity glycopolymer binding to human DC-SIGN and disruption of DC-SIGN interactions with HIV envelope glycoprotein. JAm Chem Soc 2010, 132:15130-15132.
21. Martinez-Avila O., Bedoya L.M., Marradi M., Clavel C., Alcami J., Penades S. Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells. Chembiochem 2009, 10:1806-1809.
22. Tabarani G., Reina J.J., Ebel C., Vives C., Lortat-Jacob H., Rojo J., et al. Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding. FEBS Lett 2006, 580:2402-2408.
23. Arce E., Nieto P.M., Diaz V., Castro R.G., Bernad A., Rojo J. Glycodendritic structures based on Boltorn hyperbranched polymers and their interactions with Lens culinaris lectin. Bioconjug Chem 2003, 14:817-823.
24. Maria S., Sanchez-Medina I., Mereghetti P., Belvisi L., Jimenez-Barbero J., Bernardi A. Synthesis and conformational analysis of an alpha-d-mannopyranosyl(1→2)-alpha-d-mannopyranosyl-(1→6)-alpha-d-mannopyranose mimic. Carbohydr Res 2007, 342:1859-1868.
25. Reina J.J., Sattin S., Invernizzi D., Mari S., Martinez-Prats L., Tabarani G., et al. 1,2-Mannobioside mimic: synthesis, DC-SIGN interaction by NMR and docking, and antiviral activity. ChemMedChem 2007, 2:1030-1036.
26. Canalle L.A., van Berkel S.S., de Haan L.T., van Hest J.C.M. Copper-free clickable coatings. Adv Funct Mater 2009, 19:3464-3470.
27. Xie J., Hu L., Shi W., Deng X., Cao Z., Shen Q. Synthesis and nonlinear optical properties of hyperbranched polytriazole containing second-order nonlinear optical chromophore. JPolym Sci B Polym Phys 2008, 46:1140-1148.
28. Touaibia M., Wellens A., Shiao T.C., Wang Q., Sirois S., Bouckaert J., et al. Mannosylated G(0) dendrimers with nanomolar affinities to Escherichia coli FimH. ChemMedChem 2007, 2:1190-1201.
29. Ortega-Munoz M., Lopez-Jaramillo J., Hernandez-Mateo F., Santoyo-Gonzalez F. Synthesis of glyco-silicas by Cu(I)-catalyzed "click-chemistry" and their applications in affinity chromatography. Adv Synth Catal 2006, 348:2410-2420.
30. Lambeth R.H., Pederson S.J., Baranoski M., Rawlett A.M. Methods for removal of residual catalyst from polymers prepared by ring opening metathesis polymerization. JPolym Sci A Polym Chem 2010, 48:5752-5757.
31. Tabarani G., Thepaut M., Stroebel D., Ebel C., Vives C., Vachette P., et al. DC-SIGN neck domain is a pH-sensor controlling oligomerization. SAXS and hydrodynamic studies of extracellular domain. JBiol Chem 2009, 284:21229-21240.
32. Huskens D., Vermeire K., Profy A.T., Schols D. The candidate sulfonated microbicide, PRO 2000, has potential multiple mechanisms of action against HIV-1. Antivir Res 2009, 84:38-47.
33. Andreini M., Doknic D., Sutkeviciute I., Reina J.J., Duan J.X., Chabrol E., et al. Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin. Org Biomol Chem 2011, 9:5778-5786.
34. Pieters R.J. Maximising multivalency effects in protein-carbohydrate interactions. Org Biomol Chem 2009, 7:2013-2025.
35. Geijtenbeek T.B.H., Torensma R., van Vliet S.J., van Duijnhoven G.C.F., Adema G.J., van Kooyk Y., et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100:575-585.
36. Hong P.W.P., Flummerfelt K.B., de Parseval A., Gurney K., Elder J.H., Lee B. Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding. JVirol 2002, 76:12855-12865.
37. Lin G., Simmons G., Pohlmann S., Baribaud F., Ni H.P., Leslie G.J., et al. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. JVirol 2003, 77:1337-1346.
38. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trumpfherer C., Finke J., Sun W., et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. JExp Med 2003, 197:823-829.
39. Lozach P.Y., Burleigh L., Staropoli I., Navarro-Sanchez E., Harriague J., Virelizier J.L., et al. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. JBiol Chem 2005, 280:23698-23708.
40. Hidari K.I., Abe T., Suzuki T. Carbohydrate-related inhibitors of dengue virus entry. Viruses 2013, 5:605-618.